Advertisement
News
Subscribe to MDT Magazine News

Coumadin (warfarin sodium) Crystalline 5 mg Tablets: Recall - Tablets May Have Higher than Expected Potency

May 3, 2011 7:37 am | by U.S. Food & Drug Administration | Comments

Increased risk of bleeding if there is too much active ingredient in tablet.

Immunetics lands $2.4M NIH grant for parasite detection

May 3, 2011 7:34 am | by Mass High Tech: The Journal of New England Technology | Comments

Infectious disease testing company Immunetics Inc. has won a three-year, $2.4 million Phase 2 SBIR grant from the National Institute of Allergy and Infectious Diseases, part of the National Institutes of Health.

TOPICS:

May is Older Americans Month

May 3, 2011 6:34 am | by Bio-Medicine.Org | Comments

WILMINGTON, N.C., May 3, 2011 /- Former president John F. Kennedy designated the month of May as Older Americans Month in 1963 and it has since become a long-standing tradition to pay tribute to older adults. At that time, only 17 million Americans had reached their 65th birthday,...

TOPICS:
Advertisement

Symmetry Medical to Present at the 2011 Bank of America Merrill Lynch Health Care Conference

May 3, 2011 6:34 am | by Bio-Medicine.Org | Comments

WARSAW, Ind., May 3, 2011 /- Symmetry Medical Inc. (NYSE: SMA ), a leading independent provider of products to the global orthopaedic device industry and other medical markets, announced today that Thomas J. Sullivan, President and Chief Executive Officer, and Fred L. Hite, Senior Vice...

TOPICS:

Resource Now Available to Help Clinicians Reduce Risk of Blood Exposure from Short Peripheral IV Catheter Insertion

May 3, 2011 6:33 am | by Bio-Medicine.Org | Comments

SANDY, Utah, May 3, 2011 /- Healthcare workers now have the ability to better identify risks for exposure to bloodborne pathogens, take precautions to better protect themselves, and share information and experiences as a result of a new program developed by BD Medical, a segment of BD...

TOPICS:

GenVec to Host First Quarter 2011 Earnings Call and Webcast

May 3, 2011 6:32 am | by Bio-Medicine.Org | Comments

GAITHERSBURG, Md., May 3, 2011 /- GenVec, Inc. (Nasdaq: GNVCD) announced that it will release financial results for the first quarter ended March 31, 2011 on Monday, May 9, 2011 after market close.  GenVec will hold a conference call at 10:00 a.m. EDT on Tuesday, May 10, 2011 to...

TOPICS:

Phreesia Helps Practices Manage Patients with Uncontrolled Asthma

May 3, 2011 6:32 am | by Bio-Medicine.Org | Comments

NEW YORK, May 3, 2011 /- Phreesia, the patient check-in company, announced the release of an asthma control assessment to all primary care physicians and pediatrics practices in its network. The screening tool is part of Phreesia's automated patient check-in solution and, through a series...

TOPICS:

Quest Diagnostics Announces One Day Extension of Offer to Acquire Celera to 5pm Today

May 3, 2011 6:31 am | by Bio-Medicine.Org | Comments

MADISON, N.J., May 3, 2011 /- Quest Diagnostics Incorporated (NYSE: DGX ), the world's leading provider of diagnostic testing, information and services, announced today that Spark Acquisition Corporation, its wholly owned subsidiary ("Spark"), has extended the expiration of its tender...

TOPICS:
Advertisement

Tenet Healthcare 1Q profit falls 17 pct

May 3, 2011 5:45 am | by The Associated Press | Comments

Hospital operator Tenet Healthcare Corp. said Tuesday its first quarter earnings fell 17 percent largely due to increased income taxes that offset admissions gains.The Dallas company, which is the target of a hostile takeover bid by rival Community Health Systems Inc., earned $73 million, or 14...

Amedisys agrees to buy NJ hospice

May 3, 2011 5:45 am | by The Associated Press | Comments

Home health and hospice provider Amedisys Inc. says it has agreed to buy the hospice operations of Hackensack University Medical Center in New Jersey.A sale price was not revealed Tuesday.The hospice operation has one hospice agency and one eight-bed unit that primarily serves Bergen and Hudson...

Civitas taps backers to bump Series A round to $28M

May 3, 2011 5:36 am | by Mass High Tech: The Journal of New England Technology | Comments

Civitas Therapeutics Inc., which launched in January with a $20 million Series A funding round, has now bumped that up to $28 million, according to federal documents.

Abaxis, Inc. to Present at the Bank of America Merrill Lynch 2011 Health Care Conference

May 3, 2011 5:34 am | by Bio-Medicine.Org | Comments

UNION CITY, Calif., May 3, 2011 /- Abaxis, Inc. (NasdaqGS: ABAX), a medical products company manufacturing point-of-care blood analysis systems, announced today that Clint Severson, chairman and chief executive officer,  will present at the Bank of America Merrill Lynch 2011 Health...

TOPICS:

CryoLife Completes Tender Offer for 49.9 Percent of the Outstanding Shares of Cardiogenesis Corporation

May 3, 2011 5:34 am | by Bio-Medicine.Org | Comments

ATLANTA and IRVINE, Calif., May 3, 2011 /- CryoLife, Inc. (NYSE: CRY ), an implantable biological medical device and cardiovascular tissue processing company, today announced the completion of its tender offer, through its wholly owned subsidiary CL Falcon, Inc., for 49.9 percent of the...

TOPICS:

Boston Scientific Announces CE Mark Approval and First Use of Blazerâ„¢ Open-Irrigated Catheter in Europe

May 3, 2011 5:34 am | by Bio-Medicine.Org | Comments

NATICK, Mass., May 3, 2011 /- Boston Scientific Corporation (NYSE: BSX ) today announced CE Mark approval and first use in Europe of its Blazer™ Open-Irrigated Catheter, the Company's latest radiofrequency ablation (RFA) catheter designed to treat a variety of arrhythmias such as...

TOPICS:

GenerationOne Selected by Cincinnati Children's Hospital Medical Center for Mobile Health Pilot with Teen Asthmatics

May 3, 2011 5:33 am | by Bio-Medicine.Org | Comments

MIAMI, May 3, 2011 /- GenerationOne and Cincinnati Children's Hospital Medical Center collaborated on a 14-month clinical trial for testing mobile technology in aiding the management of teenagers with Asthma. "Mobile phones represent an appealing technology for tailoring interventions and...

TOPICS:

Pages

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading